Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA003711 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA003711, RRID:AB_1854591
- Product name
- Anti-NPNT
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human NPNT, Gene description: nephronectin, Alternative Gene Names: EGFL6L, POEM, Validated applications: IHC, Uniprot ID: Q6UXI9, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Nephronectin promotes breast cancer brain metastatic colonization via its integrin-binding domains
Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs
Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin)
Magnussen S, Toraskar J, Wilhelm I, Hasko J, Figenschau S, Molnar J, Seppola M, Steigen S, Steigedal T, Hadler-Olsen E, Krizbai I, Svineng G
Scientific Reports 2020;10(1)
Scientific Reports 2020;10(1)
Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs
Steigedal T, Toraskar J, Redvers R, Valla M, Magnussen S, Bofin A, Opdahl S, Lundgren S, Eckhardt B, Lamar J, Doherty J, Hynes R, Anderson R, Svineng G
Neoplasia 2018;20(4):387-400
Neoplasia 2018;20(4):387-400
Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin)
Teo A, Garg S, Johnson T, Zhao W, Zhou J, Gomez-Sanchez C, Gurnell M, Brown M
Hypertension 2017;69(6):1207-1216
Hypertension 2017;69(6):1207-1216
No comments: Submit comment
No validations: Submit validation data